Skip to main content
Innoviva, Inc. logo

Innoviva, Inc. — Investor Relations & Filings

Ticker · INVA ISIN · US45781M1018 LEI · 549300ACOX4QTBES6535 US Financial and insurance activities
Open in API
Filings indexed 1,226 across all filing types
Latest filing 2014-08-07 Interim / Quarterly Rep…
Country US United States of America
Listing US INVA

About Innoviva, Inc.

https://www.inva.com/

Innoviva, Inc. is a diversified holding company that manages a portfolio of royalty-generating assets and operates a commercial-stage biopharmaceutical platform. The company's core royalty business is centered on respiratory therapies, providing a stable cash flow. Through its subsidiary, Innoviva Specialty Therapeutics, it focuses on developing and commercializing innovative treatments for patients in critical care and with infectious diseases. Innoviva's strategy involves leveraging its financial assets to invest in healthcare opportunities with high unmet medical needs, aiming to advance differentiated therapies and build a diverse portfolio of healthcare assets.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q2 2014
2014-08-07 English
THERAVANCE, INC. 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated August 6, 2014. It includes a press release about Theravance, Inc.'s financial results for the quarter ended June 30, 2014, and announces a cash dividend approved by the Board of Directors. The document explicitly states that the information is being furnished and not filed, and it references a press release as Exhibit 99.1. The content is typical of an earnings release announcement and dividend declaration rather than a full quarterly report or annual report. The document length is 3090 characters, which is relatively short and consistent with an earnings release or dividend announcement. Given the focus on quarterly financial results highlights and dividend announcement, the best classification is Earnings Release (ER).
2014-08-06 English
THERAVANCE, INC. 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated August 6, 2014, reporting the resignation of the CEO and appointment of a new CEO and director. It details changes in the company's board and senior management, including compensation terms and stock awards for the new CEO. There is no financial performance data or earnings information, nor is it an announcement of a report publication. The content focuses on management changes, fitting the category of Board/Management Information filings.
2014-08-06 English
FORM 4 -
Director's Dealing
2014-07-29 English
THERAVANCE 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the launch of a pharmaceutical product (ANORO) in Germany following regulatory approval. There are no financial statements, detailed financial analysis, or comprehensive report content. The document is relatively short (2562 characters) and serves as an announcement of a significant corporate event rather than a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2014-07-16 English
THERAVANCE, INC. 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated July 16, 2014. It announces the start of a global Phase 3 study for a COPD treatment by Theravance, Inc. and GlaxoSmithKline plc. The content is an event announcement rather than a detailed financial report or earnings release. The document includes a press release as an exhibit and is relatively short (2950 characters). It does not contain financial statements or detailed financial data. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2014-07-16 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.